Načítá se...
Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer that is characterized by its poor prognosis, rapid progression and development of drug resistance. Chemotherapy is a vital treatment option for most of PDAC patients. Stratification of PDAC patients, who would have a higher likel...
Uloženo v:
| Vydáno v: | Clin Proteomics |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6636003/ https://ncbi.nlm.nih.gov/pubmed/31346328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12014-019-9251-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|